FIGURE 1.
Patient disposition in the temporary authorisation for use (TAU) programme. ALK+: anaplastic lymphoma kinase positive; ROS1+: ROS proto-oncogene 1 positive; IMT: inflammatory fibroblastic tumour
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.